KOBIOLABS

KOBIOLABS is a biotech company in Seoul, South Korea, founded in 2014.

Global Top 10 Player in Microbiome Therapeutics

Headquarters
Seoul
Employees
51–200
Founded
2014
Business Model
B2B

About

KoBioLabs is a global top player in microbiome therapeutics with a mission of translating microbiome science for a better life. Its vision is to become a global leading company in innovative microbiome therapeutics and beyond, developing new therapeutic modalities based on microbiome science for immune, metabolic, and neurological disease. The company is headquartered at 1 Gwanak-ro, Gwanak-gu, Seoul, with an R&D Center in Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea.

Summary

It lists 51–200 employees.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KOBIOLABS on Indexed.vc
<a href="https://indexed.vc/companies/kobiolabs"><img src="https://indexed.vc/api/badge/company/kobiolabs" alt="KOBIOLABS on Indexed.vc" width="260" height="76" /></a>